Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
5.80
+0.10 (1.75%)
Nov 21, 2024, 12:10 PM EST - Market open
RGC Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 75 | 44 | 300 | 450 | - | - | |
| Market Cap Growth | -85.42% | -85.42% | -33.42% | - | - | - | |
| Enterprise Value | 66 | 39 | 284 | 452 | - | - | |
| Last Close Price | 5.70 | 3.36 | 23.04 | 34.60 | - | - | |
| PB Ratio | 9.02 | 5.32 | 25.01 | 26.36 | - | - | |
| P/TBV Ratio | 5.32 | 5.32 | 24.92 | 26.39 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.05 | -0.92 | -1.16 | |
| Quick Ratio | 41.13 | 41.13 | 19.06 | 28.41 | 0.01 | 0.12 | |
| Current Ratio | 41.92 | 41.92 | 19.15 | 28.46 | 0.02 | 0.12 | |
| Return on Equity (ROE) | -43.18% | -43.18% | -41.71% | -116.10% | - | - | |
| Return on Assets (ROA) | -28.11% | -28.11% | -25.59% | -51.87% | -202.15% | -134.09% | |
| Return on Capital (ROIC) | -28.52% | -28.52% | -25.88% | -54.30% | -1670.73% | -153.32% | |
| Earnings Yield | -5.80% | -9.84% | -1.96% | -1.65% | - | - | |
| FCF Yield | -5.40% | -9.16% | -1.66% | -1.34% | - | - | |
| Buyback Yield / Dilution | - | -1.62% | -28.06% | - | - | |
| Total Shareholder Return | - | -1.62% | -28.06% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.